Skip to main content

Clinical Pathways promote evidence-based, safe, and high-value patient care by providing clinical recommendations and standard processes. They are developed by multidisciplinary committees of subject matter experts, informed by a methodical review of available evidence and consensus among committee members. 

Dizziness-Vertigo Clinical Pathway: 

 Inclusion and exclusion criteria: 

  • Inclusion: 
    • Patient with complaint of symptoms consistent with dizziness or vertigo
  • Exclusion: 
    • Acute illness with associated dizziness or vertigo
    • Syncope
    • Known concussion or recent head injury
    • Known Positional Orthostatic Tachycardia Syndrome (POTS) 

 Committee members involved in the development: 

  • Trisha Williams, RN, APRN, CPN, CPNP | Otolaryngology | Committee Co-Chair
  • Lara Koral, MSN, FNP-BC | Neurology | Committee Co-Chair
  • Katie Senn, MD | General Academic Pediatrics | Committee Member 
  • Rachel Whitfield, MSN, APRN, FNP-C | Adolescent Medicine | Committee Member
  • Stacey Shoman, APRN | Premier Pediatrics | Committee Member 
  • Andrea Thorne, PT | Physical & Occupational Therapy | Committee Member

Consultants: 

  • Stephani Stancil, PhD, APRN | Adolescent Medicine, Clinical Pharmacology and Toxicology 
  • Julie Martin, RN, MSN, FNP-BC, PNP-BC | Heart Center
  • Laura Martis, MSN, RN, CPNP-AC | Heart Center
  • Lindsey Malloy Walton, DO, MPH | Heart Center
  • Amanda Nedved, MD | Urgent Care 
  • Gina Jones, DO | Neurology
  • Trevor Gerson, MD | Neurology 

EBP Committee Members: 

  • Kathleen Berg, MD, FAAP | Hospitalist, Evidence Based Practice
  • Andrea Melanson, OTD, OTR/L | Evidence Based Practice 

 Publication dates: 

  • Finalized date: 04/2025
  • Next expected revision date: April 2028 

 Concerns with content: 

If you have any questions regarding this content or identify a broken link, please email evidencebasedpractice@cmh.edu.